NEXGEL, Inc. (NXGL) stock
NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$3.60−0.19 (-5.13%)
Close on Nov 18, 2026Market cap $1.76MP/E –Yield –
Nexgel pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Nexgel
Nexgel has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?